Dear Editors
We have reviewed the autopsy materials “Pathology of Atomic Bomb Casualties” (Leibow et al. 1949) and “Medical Effects of the Atomic Bomb in Japan” (Oughterson and Warren 1956). To some degree the cause of death to the casualties of Hiroshima and Nagasaki was similar to the cause of death from any massive explosion associated with blast injuries, heat (burns), and trauma from collapsing buildings, etc. As it has been well established, the effect of radiation, however, triggered a whole new panorama of injuries. Radiation sickness produced nausea, vomiting, dehydration as well as destruction of the patient’s bone marrow and lymphoid tissue.
Most of the illness and death that occurred after two weeks was the direct and indirect effect of a compromised immune system (Table I). The pathologists evaluating the autopsy materials noted that around two weeks after the explosion, there was a drop in the death rate for about 5 days and then a rise again. They also noted that this rise could be due to “patients’ pre-existing injuries”. The partial recovery, noted in the autopsies of the patients bone marrow, did not occur until 40 – 50 days after the explosion. The compromised immune system, and the lack of antibiotics, resulted in infection, poor healing, ulceration, hemorrhage, pneumonia, and death. There is every reason to believe that if antibiotics can protect the patients until the marrow recovers, such adverse effects would be reduced.
Table I.
Important Anatomic Changes in Severe “Radiation Effect”
| Tissue | Group I Patients dying in weeks 1 and 2 |
Group II* Patients dying in weeks 3, 4, 5, 6 |
Group III+ Patients dying after week 6 |
|---|---|---|---|
|
| |||
| Adipose tissue | Usually no depletion | Occasionally depletion | Usually depletion |
| Lung | Occasional hemorrhage and edema | Necrosis and hemorrhage | Focal necrotizing or organizing pneumonitis |
| Bone marrow |
|
Usually
Occasionally
|
Usually
Occasionally
|
| Lymph nodes and spleen | Extreme decrease of small lymphocytes | As in group I, and atypical mononuclear cells | As in group II, and occasionally regeneration of lymphoid tissue |
| Gastro-Intestinal tract | Atypical mitotic figures and epithelial cells | Necrosis, hemorrhage, and ulceration | Necrosis and ulceration |
| Neck organs | Atypical mitotic figures and epithelial cells | Necrosis, hemorrhage, and ulceration | Focal necrosis and ulceration |
| Skin | Unknown | Petechiae and necrosis, atrophy of hair follicles | Regeneration of hair follicles; usually no other changes |
| Gonads (especially testis) | Incipient atrophy | Severe atrophy | Extreme atrophy |
No polymorphonuclear cells in lesions
Polymorphonuclear cells in lesions
No distinction is made in this table between the direct effects of ionizing radiation and the indirect effects resulting from infection, etc. (Reproduced from Am J Pathol 1949, 25:853-1027 with permission from the American Society for Investigative Pathology)
The pathologists of The Joint Commission, who began evaluating the autopsy materials only 6 weeks after the explosion, suggested at the end of their study that only 5–10 % of the deceased could have been saved. However, the only antibiotics available to the Japanese physicians at the time of the explosion were sulfa compounds used in low doses. In their conclusion, the pathologist noted: “pending the resurrection of the bone marrow, the main therapeutic problems are those of hemorrhage and infection.”
From review of the pathological materials described in the report (Leibow et al. 1949), the casualties could potentially have been treated with marrow replacement and antibiotics. The current availability of advanced antibiotics and human cord blood for marrow replacement from the National Cord Blood depositories, coupled with readily available intravenous fluids, would, in our opinion, save 80 to 90% of those who survive the first 72 hours following an accidental or intentional nuclear detonation. In addition, the long term effects of radiation could be mitigated. This would require, however, hundreds of volunteers to administer fluids and an organized coordinated plan. Currently, such a national large scale coordinated plan does not exist.
Acknowledgments
Research in the laboratories of the authors is supported by the Abraham S. Ende Foundation, the National Institutes of Health (Grant CA049062), the National Aeronautics and Space Administration (Grant NNJ06HD91) and by the Department of Energy (Grant FG02-02ER63447).
Contributor Information
NORMAN ENDE, Department of Pathology and Laboratory Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, USA.
EDOUARD I. AZZAM, Department of Radiology, UMDNJ-New Jersey Medical School Cancer Center, Newark, New Jersey, USA
References
- Liebow AA, Warren S, DeCoursey E. Pathology of atomic bomb casualties. The American Journal of Pathology. 1949;XXV:853–1027. [PMC free article] [PubMed] [Google Scholar]
- Oughterson AW, Warren S. Manhattan Project Technical Section. Vol. 8. New York: McGraw-Hill; 1956. Medical Effects of the Atomic Bomb in Japan (National nuclear energy series. Division VIII. [Google Scholar]
